NCT04645628

Brief Summary

The purpose of this study is to evaluate the optimization of MRI acquisition sequences.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
720

participants targeted

Target at P75+ for not_applicable

Timeline
31mo left

Started Dec 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Dec 2020Dec 2028

First Submitted

Initial submission to the registry

November 16, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 27, 2020

Completed
7 days until next milestone

Study Start

First participant enrolled

December 4, 2020

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2027

Expected
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

7 years

First QC Date

November 16, 2020

Last Update Submit

March 2, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Image quality based on standard imaging quality criteria.

    The image quality will be appreciated visually at least by a radiologist or a researcher.

    6 months after the last inclusion

Secondary Outcomes (7)

  • Comparison of the Signal to Noise Ratio obtained by the optimized MRI sequence and the reference situation (standard sequence).

    6 months after the last inclusion

  • Comparison of the Contrast to Noise Ratio obtained by the optimized MRI sequence and the reference situation (standard sequence).

    6 months after the last inclusion

  • Comparison of the acquisition time obtained with the optimized MRI sequence and the reference situation (standard sequence).

    6 months after the last inclusion

  • Comparison of blurring and artefacts obtained by the optimized MRI sequence and the reference situation (standard sequence).

    6 months after the last inclusion

  • Comparison of the spatial resolution obtained by the optimized MRI sequence and the reference situation (standard sequence).

    6 months after the last inclusion

  • +2 more secondary outcomes

Study Arms (1)

All subjects will have an MRI examination

EXPERIMENTAL
Other: MRI examination

Interventions

All subjects (healthy subjects and patients) will have an MRI examination with optimized sequences

All subjects will have an MRI examination

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • to be over 18 year-old,
  • to be able to understand the instructions given,
  • to be enrolled in a social security plan,
  • to give a written consent.
  • to perform a MRI examination of the head, neck, spine, thorax, abdomen, pelvis, retroperitoneum, lower limbs, upper limbs or whole body during clinical follow-up care.

You may not qualify if:

  • any contraindication to MR examination (active medical device, ferromagnetic foreign body, pregnancy, morbid obesity, claustrophobia, … ),
  • subject under a measure of legal protection.
  • to have a pathology in the anatomical area to be imaged
  • to be employed by the CHRU of Nancy or having the slightest link of subordination with the CHRU of Nancy.
  • to have a limited MRI examination time due to a sensitive clinical situation (sedation, unstable hemodynamic state, postoperative).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU de Nancy

Nancy, 5400, France

RECRUITING

Related Publications (5)

  • He Z, Soullie P, Lefebvre P, Ambarki K, Felblinger J, Odille F. Changes of in vivo electrical conductivity in the brain and torso related to age, fat fraction and sex using MRI. Sci Rep. 2024 Jul 12;14(1):16109. doi: 10.1038/s41598-024-67014-9.

  • Caron B, Laurent V, Odille F, Danese S, Hossu G, Peyrin-Biroulet L. New magnetic resonance imaging sequences for fibrosis assessment in Crohn's disease: a pilot study. Scand J Gastroenterol. 2022 Dec;57(12):1450-1453. doi: 10.1080/00365521.2022.2094727. Epub 2022 Sep 29.

  • Boubaker F, Lane JI, Puel U, Drouot G, Witte RJ, Ambarki K, Gondim-Teixeira PA, Blum A, Parietti-Winkler C, Vallee JN, Gillet R, Eliezer M. High-Resolution 3T MRI of the Membranous Labyrinth Using Deep Learning Reconstruction. AJNR Am J Neuroradiol. 2026 Mar 4;47(3):723-729. doi: 10.3174/ajnr.A8989.

  • Gillet R, Boubaker F, Clara M, Ambarki K, Stemmer A, Drouot G, Gillet P, Gondim Teixeira PA, Blum A. Optimizing knee MRI: 3D proton density turbo spin echo nDixon sequence vs. 2D high-resolution turbo spin echo in half the acquisition time. Eur J Radiol. 2026 Feb;195:112552. doi: 10.1016/j.ejrad.2025.112552. Epub 2025 Nov 19.

  • Wary P, Hossu G, Ambarki K, Nickel D, Arberet S, Oster J, Orry X, Laurent V. Deep learning HASTE sequence compared with T2-weighted BLADE sequence for liver MRI at 3 Tesla: a qualitative and quantitative prospective study. Eur Radiol. 2023 Oct;33(10):6817-6827. doi: 10.1007/s00330-023-09693-y. Epub 2023 May 16.

Central Study Contacts

Valérie LAURENT, MD, PhD

CONTACT

Gabriela HOSSU, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

November 16, 2020

First Posted

November 27, 2020

Study Start

December 4, 2020

Primary Completion (Estimated)

December 8, 2027

Study Completion (Estimated)

December 1, 2028

Last Updated

March 4, 2026

Record last verified: 2026-03

Locations